Simran Venkatraman

11PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2025
Potassium channels mediate the inhibitory effect of exosomes on anti-tumor immunity in head and neck cancer.

Ameet A Chimote, Abdulaziz O Alshwimi, Simran Venkatraman

|Jul 29, 2025
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro.

Paul L Deford, Andrew P VonHandorf, Brian G Hunt

|Jan 08, 2025
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.

Simran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha

|Feb 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman

|Dec 19, 2023
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.

Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman

|May 13, 2023
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.

Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman

Pageof 2

Frequent Collaborators

8 joint publications

Brinda Balasubramanian

7 joint publications

Rutaiwan Tohtong

6 joint publications

Tavan Janvilisri

4 joint publications

Somchai Chutipongtanate